Nu Skin Enterprises Stock Cash And Equivalents

NUS Stock

USD 8.34 0.01 0.12%

Fundamental analysis of Nu Skin allows traders to better anticipate movements in Nu Skin's stock price by examining its financial health and performance throughout various phases of its business cycle.

		Last Reported	Projected for Next Year
	Cash And Equivalents	186.9 M	262.8 M

Cash And Equivalents is likely to gain to about 262.8 M in 2025.

Build AI portfolio with NUS Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nu Skin Enterprises Company Cash And Equivalents Analysis

Nu Skin's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Nu Skin Cash And Equivalents

186.88 M

Most of Nu Skin's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nu Skin Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

NUS Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Nu Skin is extremely important. It helps to project a fair market value of NUS Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Nu Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nu Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nu Skin's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Good Will	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.96	0.23	0.95	0.75	0.8	0.97	0.9	0.23	0.53	-0.18	-0.52	0.59	0.9	-0.53	0.26	-0.79	0.84	0.52	0.73	-0.3	-0.02	0.39	0.36	0.17	0.22
Total Stockholder Equity	0.96		0.14	0.88	0.66	0.7	0.86	0.89	0.2	0.46	-0.23	-0.59	0.43	0.84	-0.61	0.27	-0.65	0.84	0.35	0.61	-0.23	0.01	0.33	0.38	0.21	0.14
Net Debt	0.23	0.14		0.44	-0.2	0.23	0.29	-0.18	-0.02	0.52	0.07	0.35	0.77	0.4	0.05	-0.43	-0.72	0.46	0.83	0.78	-0.68	-0.68	0.65	-0.04	-0.49	0.77
Retained Earnings	0.95	0.88	0.44		0.57	0.7	0.94	0.72	0.22	0.55	-0.26	-0.38	0.77	0.93	-0.48	0.05	-0.89	0.84	0.67	0.84	-0.4	-0.17	0.4	0.32	0.14	0.37
Accounts Payable	0.75	0.66	-0.2	0.57		0.75	0.78	0.88	0.07	0.3	0.0	-0.49	0.21	0.49	-0.4	0.65	-0.42	0.49	0.21	0.35	-0.08	0.18	0.19	0.27	0.18	0.01
Net Receivables	0.8	0.7	0.23	0.7	0.75		0.82	0.71	-0.15	0.52	0.32	-0.28	0.54	0.67	-0.38	0.39	-0.59	0.72	0.56	0.64	-0.51	-0.23	0.4	0.26	0.05	0.27
Total Liab	0.97	0.86	0.29	0.94	0.78	0.82		0.84	0.24	0.56	-0.12	-0.42	0.69	0.89	-0.44	0.24	-0.85	0.79	0.62	0.79	-0.35	-0.04	0.41	0.32	0.13	0.27
Total Current Assets	0.9	0.89	-0.18	0.72	0.88	0.71	0.84		0.27	0.31	-0.19	-0.63	0.24	0.71	-0.56	0.5	-0.49	0.67	0.18	0.41	0.01	0.25	0.18	0.31	0.26	-0.06
Short Term Debt	0.23	0.2	-0.02	0.22	0.07	-0.15	0.24	0.27		0.23	-0.26	-0.15	0.01	0.27	0.28	-0.02	-0.24	0.11	-0.1	0.19	0.46	0.32	0.16	0.12	0.21	0.02
Good Will	0.53	0.46	0.52	0.55	0.3	0.52	0.56	0.31	0.23		0.36	-0.39	0.62	0.43	0.19	0.01	-0.65	0.35	0.62	0.67	-0.44	-0.07	0.88	0.71	0.16	0.36
Intangible Assets	-0.18	-0.23	0.07	-0.26	0.0	0.32	-0.12	-0.19	-0.26	0.36		0.04	0.0	-0.26	0.3	0.11	0.17	-0.2	0.09	-0.05	-0.17	-0.05	0.3	0.15	0.02	0.01
Common Stock	-0.52	-0.59	0.35	-0.38	-0.49	-0.28	-0.42	-0.63	-0.15	-0.39	0.04		-0.06	-0.32	0.36	-0.28	0.13	-0.07	0.05	0.04	-0.23	-0.61	-0.17	-0.75	-0.67	0.41
Long Term Debt	0.59	0.43	0.77	0.77	0.21	0.54	0.69	0.24	0.01	0.62	0.0	-0.06		0.74	-0.17	-0.35	-0.88	0.54	0.96	0.86	-0.64	-0.38	0.52	0.28	-0.04	0.51
Property Plant Equipment	0.9	0.84	0.4	0.93	0.49	0.67	0.89	0.71	0.27	0.43	-0.26	-0.32	0.74		-0.51	-0.05	-0.83	0.83	0.63	0.78	-0.37	-0.12	0.29	0.23	0.11	0.26
Current Deferred Revenue	-0.53	-0.61	0.05	-0.48	-0.4	-0.38	-0.44	-0.56	0.28	0.19	0.3	0.36	-0.17	-0.51		-0.05	0.28	-0.53	-0.15	-0.15	0.03	0.05	0.14	0.15	0.1	0.04
Short Term Investments	0.26	0.27	-0.43	0.05	0.65	0.39	0.24	0.5	-0.02	0.01	0.11	-0.28	-0.35	-0.05	-0.05		0.08	0.14	-0.28	-0.1	0.13	0.24	0.0	0.03	0.09	-0.11
Treasury Stock	-0.79	-0.65	-0.72	-0.89	-0.42	-0.59	-0.85	-0.49	-0.24	-0.65	0.17	0.13	-0.88	-0.83	0.28	0.08		-0.75	-0.86	-0.95	0.53	0.31	-0.63	-0.21	0.18	-0.57
Net Tangible Assets	0.84	0.84	0.46	0.84	0.49	0.72	0.79	0.67	0.11	0.35	-0.2	-0.07	0.54	0.83	-0.53	0.14	-0.75		0.53	0.8	-0.47	-0.42	0.36	-0.02	-0.22	0.49
Long Term Debt Total	0.52	0.35	0.83	0.67	0.21	0.56	0.62	0.18	-0.1	0.62	0.09	0.05	0.96	0.63	-0.15	-0.28	-0.86	0.53		0.85	-0.69	-0.5	0.63	0.18	-0.26	0.62
Capital Surpluse	0.73	0.61	0.78	0.84	0.35	0.64	0.79	0.41	0.19	0.67	-0.05	0.04	0.86	0.78	-0.15	-0.1	-0.95	0.8	0.85		-0.63	-0.47	0.65	0.16	-0.24	0.67
Short Long Term Debt	-0.3	-0.23	-0.68	-0.4	-0.08	-0.51	-0.35	0.01	0.46	-0.44	-0.17	-0.23	-0.64	-0.37	0.03	0.13	0.53	-0.47	-0.69	-0.63		0.56	-0.45	-0.16	0.3	-0.44
Cash And Equivalents	-0.02	0.01	-0.68	-0.17	0.18	-0.23	-0.04	0.25	0.32	-0.07	-0.05	-0.61	-0.38	-0.12	0.05	0.24	0.31	-0.42	-0.5	-0.47	0.56		-0.29	0.35	0.58	-0.84
Net Invested Capital	0.39	0.33	0.65	0.4	0.19	0.4	0.41	0.18	0.16	0.88	0.3	-0.17	0.52	0.29	0.14	0.0	-0.63	0.36	0.63	0.65	-0.45	-0.29		0.46	-0.25	0.58
Net Working Capital	0.36	0.38	-0.04	0.32	0.27	0.26	0.32	0.31	0.12	0.71	0.15	-0.75	0.28	0.23	0.15	0.03	-0.21	-0.02	0.18	0.16	-0.16	0.35	0.46		0.68	-0.17
Capital Stock	0.17	0.21	-0.49	0.14	0.18	0.05	0.13	0.26	0.21	0.16	0.02	-0.67	-0.04	0.11	0.1	0.09	0.18	-0.22	-0.26	-0.24	0.3	0.58	-0.25	0.68		-0.52
Long Term Investments	0.22	0.14	0.77	0.37	0.01	0.27	0.27	-0.06	0.02	0.36	0.01	0.41	0.51	0.26	0.04	-0.11	-0.57	0.49	0.62	0.67	-0.44	-0.84	0.58	-0.17	-0.52

Click cells to compare fundamentals

NUS Cash And Equivalents Historical Pattern

Today, most investors in Nu Skin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nu Skin's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nu Skin cash and equivalents as a starting point in their analysis.

Nu Skin Cash And Equivalents

Timeline

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Nu Skin

Cash And Equivalents Over Time

In accordance with the recently published financial statements, Nu Skin Enterprises has 186.88 M in Cash And Equivalents. This is 87.01% lower than that of the Personal Care Products sector and 84.43% lower than that of the Consumer Staples industry. The cash and equivalents for all United States stocks is 93.08% higher than that of the company.

NUS Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.

Nu Skin is currently under evaluation in cash and equivalents category among its peers.

Nu Skin ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nu Skin's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nu Skin's managers, analysts, and investors.

Environmental

Governance

Social

NUS Fundamentals

	Return On Equity	-0.0493
	Return On Asset	0.0354
	Profit Margin	(0.02) %
	Operating Margin	0.04 %
	Current Valuation	498.77 M
	Shares Outstanding	49.41 M
	Shares Owned By Insiders	2.23 %
	Shares Owned By Institutions	75.78 %
	Number Of Shares Shorted	1.98 M
	Price To Earning	10.70 X
	Price To Book	0.54 X
	Price To Sales	0.25 X
	Revenue	1.73 B
	Gross Profit	1.17 B
	EBITDA	(78.83 M)
	Net Income	(146.59 M)
	Cash And Equivalents	186.88 M
	Cash Per Share	7.69 X
	Total Debt	478.23 M
	Debt To Equity	0.59 %
	Current Ratio	2.30 X
	Book Value Per Share	15.26 X
	Cash Flow From Operations	111.74 M
	Short Ratio	3.74 X
	Earnings Per Share	(0.81) X
	Price To Earnings To Growth	2.35 X
	Target Price	7.5
	Number Of Employees	3.1 K
	Beta	0.89
	Market Capitalization	411.61 M
	Total Asset	1.47 B
	Retained Earnings	1.71 B
	Working Capital	241.99 M
	Current Asset	706.39 M
	Current Liabilities	407.6 M
	Annual Yield	0.03 %
	Five Year Return	3.09 %
	Net Asset	1.47 B
	Last Dividend Paid	0.24

About Nu Skin Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC